Want to see CTKB full AI Analyst Report?
Cytek Biosciences (CTKB) Ownership Overview
8.47% Insiders
13.06% Mutual Funds
12.38% Other Institutional Investors
11.52% ETFs
54.56% Public Companies and
Individual Investors
The ownership structure of Cytek Biosciences (CTKB) stock is a mix of institutional, retail, and individual investors. Approximately 36.97% of the company’s stock is owned by Institutional Investors, 8.47% is owned by Insiders, and 54.56% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $9221395 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $101319 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,961,544 | Institution | 4.59% | 28,019,257 | |
| 5,561,029 | Insider | 4.28% | 26,136,836 | |
| 5,456,837 | Institution | 4.20% | 25,647,134 | |
| 4,821,870 | Insider | 3.71% | 22,662,789 | |
| 4,640,930 | Institution | 3.57% | 21,812,371 | |
| 2,081,579 | Institution | 1.60% | 9,783,421 | |
| 1,336,245 | Institution | 1.03% | 6,280,352 | |
| 1,325,697 | Institution | 1.02% | 6,230,776 | |
| 1,156,430 | Institution | 0.89% | 5,435,221 | |
| 1,115,847 | Institution | 0.86% | 5,244,481 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,640,930 | Institution | 3.57% | 21,812,371 | |
| 1,336,245 | Institution | 1.03% | 6,280,352 | |
| 1,325,697 | Institution | 1.02% | 6,230,776 | |
| 1,115,847 | Institution | 0.86% | 5,244,481 | |
| 1,059,515 | Institution | 0.82% | 4,979,721 | |
| 770,470 | Institution | 0.59% | 3,621,209 | |
| 692,936 | Institution | 0.53% | 3,256,799 | |
| 679,496 | Institution | 0.52% | 3,193,631 | |
| 643,363 | Institution | 0.49% | 3,023,806 | |
| 538,961 | Institution | 0.41% | 2,533,117 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,525,848 | Institution | 2.71% | 14,879,079 | |
| 3,115,405 | Institution | 2.40% | 14,642,404 | |
| 1,303,002 | Institution | 1.00% | 5,498,668 | |
| 1,130,565 | Institution | 0.87% | 5,313,656 | |
| 882,961 | Institution | 0.68% | 4,149,917 | |
| 684,567 | Institution | 0.53% | 2,888,873 | |
| 568,920 | Institution | 0.44% | 2,673,924 | |
| 525,107 | Institution | 0.40% | 2,468,003 | |
| 385,136 | Institution | 0.30% | 1,706,152 | |
| 372,840 | Institution | 0.29% | 1,752,348 |
FAQ
Who Owns Cytek Biosciences (CTKB)?
According to the latest TipRanks data, approximately 12.38% of the company's stock is held by institutional investors, 8.47% is held by insiders, and 54.56% is held by retail investors.
What percentage of Cytek Biosciences (CTKB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.38% of Cytek Biosciences (CTKB) stock is held by institutional investors.
What percentage of Cytek Biosciences (CTKB) stock is held by retail investors?
According to the latest TipRanks data, approximately 54.56% of Cytek Biosciences (CTKB) stock is held by retail investors.
Who owns the most shares of Cytek Biosciences (CTKB)?
Vanguard owns the most shares of Cytek Biosciences (CTKB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.